CareDx (CDNA) entered a definitive agreement to divest its Lab Products business to Eurobio Scientific for $170M in cash, sharpening focus on its Testing Services and Patient & Digital Solutions businesses.
Key facts
AnnouncedApr 28, 2026
Deal value$170M
Deal typeAsset Purchase
Therapeutic areatransplant diagnostics
Indicationstransplant diagnostics
Key assetsCareDx Lab Products business (transplant diagnostics laboratory products line)